U.S. market Open. Closes in 3 hours 2 minutes

BLPH | Bellerophon Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue65.00K102.00K147.00K348.00K362.00KN/AN/AN/AN/AN/AN/A
Gross Profit-65.00K-102.00K-147.00K-348.00K-362.00KN/AN/AN/AN/AN/AN/A
Operating Expenses22.38M20.16M26.28M17.47M27.88M24.60M23.76M48.23MN/AN/AN/A
Selling, General & Admin6.02M7.15M8.39M6.44M7.62MN/AN/AN/AN/A9.01MN/A
Research & Development16.36M13.02M17.89M11.03M20.26MN/AN/AN/A45.98M52.98M38.73M
Other Operating ExpensesN/AN/AN/A-674.00K27.88M24.60M23.76M48.23MN/AN/AN/A
Operating Income-22.38M-20.16M-26.28M-17.47M-27.88M-24.60M-23.76MN/A-59.75M-62.00M-46.23M
Other Expenses / Income136.00K605.00K-577.00K2.40M24.88MN/AN/AN/A79.00KN/AN/A
Before Tax Income-22.25M-19.56M-26.85M-15.07M-2.62MN/AN/AN/A-59.67M-62.00M-46.23M
Income Tax Expenses-2.42M-1.80M-2.12M-1.80M-5.44MN/AN/AN/AN/AN/AN/A
Net Income-19.83M-17.76M-24.73M-13.27M2.81MN/AN/AN/A-59.67M-62.00M-46.23M
Interest Expenses135.00K5.00K250.00KN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding9.55M9.50M7.80M4.50M4.34M2.60M1.00M817.85K793.69K860.36K860.36K
Diluted Shares Outstanding9.55M9.50M7.80M4.50M4.34M2.60M1.00M817.85K793.69K860.36K860.36K
EBITDA-22.39M-20.76M-26.13M-19.81M-52.40MN/AN/AN/A-59.37M-61.57M-46.14M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-22.11M-19.55M-26.60M-15.07M-2.62MN/AN/AN/A-59.67M-62.00M-46.23M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙